Tryp Therapeutics Inc (TRYP) Corporate Media Kit

James Gilligan, Ph.D. President and Chief Science Officer Dr. James Gilligan has over 35 years of experience in the life sciences industry, including research and development, clinical development, international regulatory affairs and manufacturing. Before assuming his role with Tryp, Dr. Gilligan was the Co-Founder and Managing Partner of The Bracken Group, a life sciences consulting firm. He also co-founded Unigene Laboratories, which develops technology for the recombinant manufacture of peptide hormones. Dr. Gilligan holds a Ph.D. in phar- macology from the University of Connecticut and a MSIB from Seton Hall University. He continued his post-graduate education at the Roche Institute of Molecular Biology.